307 related articles for article (PubMed ID: 38611815)
1. [
Deleuziere M; Benoist É; Quelven I; Gras E; Amiens C
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611815
[TBL] [Abstract][Full Text] [Related]
2.
Faivre L; Chaussard M; Vercellino L; Vanneaux V; Hosten B; Teixera K; Parietti V; Merlet P; Sarda-Mantel L; Rizzo-Padoin N; Larghero J
Curr Res Transl Med; 2016; 64(3):141-148. PubMed ID: 27765274
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in cardiovascular disease.
Beanlands R
Can J Cardiol; 1996 Oct; 12(10):875-83. PubMed ID: 9191475
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
[TBL] [Abstract][Full Text] [Related]
6. Development of [
Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Zakavi SR; Caldarella C; Muoio B; Bertagna F; Ceriani L; Giovanella L
Foot (Edinb); 2013 Dec; 23(4):140-8. PubMed ID: 23906976
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.
Annunziata S; Pizzuto DA; Caldarella C; Galiandro F; Sadeghi R; Treglia G
World J Gastroenterol; 2015 Oct; 21(40):11481-8. PubMed ID: 26523112
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
Sadeghi R; Zakavi SR; Hasanzadeh M; Treglia G; Giovanella L; Kadkhodayan S
Int J Gynecol Cancer; 2013 Oct; 23(8):1349-56. PubMed ID: 23945203
[TBL] [Abstract][Full Text] [Related]
10. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
[TBL] [Abstract][Full Text] [Related]
12. Magnetically driven nanoparticles:
De Simone M; Panetta D; Bramanti E; Giordano C; Salvatici MC; Gherardini L; Menciassi A; Burchielli S; Cinti C; Salvadori PA
Contrast Media Mol Imaging; 2016 Nov; 11(6):561-571. PubMed ID: 28052582
[TBL] [Abstract][Full Text] [Related]
13. A review of approaches to
Morris O; Fairclough M; Grigg J; Prenant C; McMahon A
J Labelled Comp Radiopharm; 2019 Jan; 62(1):4-23. PubMed ID: 29740878
[TBL] [Abstract][Full Text] [Related]
14. The role of
Ayubcha C; Hosoya H; Seraj SM; Zadeh MZ; Werner T; Alavi A
Hell J Nucl Med; 2019; 22(1):4-5. PubMed ID: 30843002
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Prior JO; Bertagna F; Ceriani L; Giovanella L
Lung Cancer; 2014 Jan; 83(1):1-7. PubMed ID: 24290256
[TBL] [Abstract][Full Text] [Related]
16. Advances in [
Francis F; Wuest F
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770885
[TBL] [Abstract][Full Text] [Related]
17. Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET.
Nagachinta S; Becker G; Dammicco S; Serrano ME; Leroi N; Bahri MA; Plenevaux A; Lemaire C; Lopez R; Luxen A; de la Fuente M
Colloids Surf B Biointerfaces; 2020 Apr; 188():110793. PubMed ID: 31982792
[TBL] [Abstract][Full Text] [Related]
18. Methods for Radiolabelling Nanoparticles: PET Use (Part 2).
Bentivoglio V; Varani M; Lauri C; Ranieri D; Signore A
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291726
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review.
Treglia G; Taralli S; Calcagni ML; Maggi F; Giordano A; Bonomo L
J Comput Assist Tomogr; 2011; 35(3):387-93. PubMed ID: 21586936
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.
Treglia G; Quartuccio N; Sadeghi R; Farchione A; Caldarella C; Bertagna F; Fania P; Cistaro A
J Crohns Colitis; 2013 Jun; 7(5):345-54. PubMed ID: 22960135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
